Gracell Biotechnologies IPO: Promising Early Trial Results but Nowhere Close to Commercialisation
Gracell Biotechnologies is a clinical-stage biopharmaceutical company dedicated to developing breakthrough cell therapies for treating cancer. In...
428 Views
Pre-IPO Bio-Thera Solutions - Insights on Pipeline and the Competitive Landscape
This article summarized the insights on major products of Bio-Thera Solutions in the pipeline and related competitive landscape with other key...
336 Views
What HKEX Biotech "Step-Ups" Can Tell Us
This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...
343 Views
ECM Weekly (11 October 2020) - Excellence Comm, MR DIY, Converge ICT, Simcere, SciClone, JW Thera
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...
367 Views
JHBP/Genor (嘉和生物) IPO Trading: Visible Upsides
JHBP/Genor raised HKD 2,694 million (USD 348 m) from its global offering and will list on the Hong Kong Stock Exchange tomorrow. In our previous...
354 Views